首页> 外文期刊>Hospital pharmacy. >Risk Factors for Recurrent Clostridium difficile Infections and Strategies to Decrease Readmissions in a Community Hospital
【24h】

Risk Factors for Recurrent Clostridium difficile Infections and Strategies to Decrease Readmissions in a Community Hospital

机译:难治性梭状芽胞杆菌感染的危险因素及减少社区医院再入院的策略

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Currently there are no universally accepted approaches for the prevention of recurrent Clostridium difficile infections (CDI) following the initial infection. Several studies have identified common risk factors for the emergence of recurrent CDI. Identifying patients at high risk for recurrent CDI through the assessment of risk factors at initial diagnosis could enable health care providers to optimize available treatment options. A vancomycin hydrochloride-tapered regimen may be an effective treatment option for the prevention of recurrent CDI following the initial infection.Methods: In this single-center, prospective study, we examined the efficacy of orally administered vancomycin-tapered regimens for the prevention of recurrent CDI in high-risk patients. High-risk patients were identified using patient risk factors found in a retrospective chart review. The primary objective was to decrease hospital readmissions for recurrent CDI. The secondary objective was to improve the discharge coordination-of-care process by providing a pharmacy benefits evaluation, which ensured vancomycin affordability and assistance in prescription attainment, and discharge counseling.
机译:背景:目前尚无普遍接受的预防最初感染后再次发生艰难梭菌感染的方法。几项研究确定了复发性CDI出现的常见危险因素。通过在初诊时评估风险因素来识别复发性CDI的高风险患者,可使医疗保健提供者优化可用的治疗方案。盐酸万古霉素锥形疗法可能是预防初始感染后复发CDI的有效治疗方法。方法:在这项单中心前瞻性研究中,我们研究了口服万古霉素锥形疗法预防复发的疗效。高危患者的CDI。使用回顾性图表审查中发现的患者危险因素识别高危患者。主要目的是减少因再次发生CDI而住院的人数。第二个目标是通过提供药房效益评估来改善出院护理的协调过程,该评估确保了万古霉素的可负担性和处方制定方面的协助以及出院咨询。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号